|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 10, 2015 ) Hereditary Angioedema (HAE) - Pipeline Review, H1 2015
RnRMarketResearch.com Adds “Hereditary Angioedema (HAE) - Pipeline Review, H1 2015” which provides an overview of the Hereditary Angioedema (HAE) therapeutic pipeline.
This report gives far reaching data on the helpful advancement for Hereditary Angioedema (HAE), complete with relative examination at different stages, therapeutics appraisal by medication target, component of activity (MoA), course of organization (RoA) and particle sort, alongside most recent upgrades, and included news and press discharges. It additionally surveys key players included in the restorative improvement for Hereditary Angioedema (HAE) and extraordinary components on late-stage and ended activities.
The report improves choice making capacities and help to make powerful counter techniques to increase upper hand. It reinforces R&D pipelines by recognizing new targets and MOAs to create first-in-class and best-in-class items.
Complete report on H1, 2015 Pipeline Review of “Hereditary Angioedema (HAE)” addition with 25 market data tables and 14 figures, spread across 78 pages is http://www.rnrmarketresearch.com/hereditary-angioedema-hae-pipeline-review-h1-2015-market-report.html .
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Drugs Profile Discussed in this Research :
BCX-4161, BCX-7353, BEL-0215, C1 esterase inhibitor (human), C1 esterase inhibitor (human), C1 esterase inhibitor (recombinant), C1 esterase inhibitor (recombinant), CSL-312, DX-2930, icatibant acetate, ISIS-PKKRx, Recombinant Protein to Inhibit C1-esterase for Hereditary Angioedema, Small Molecule 2 to Inhibit Plasma Kallikrein for Hereditary Angioedema, Small Molecule for Hereditary Angioedema and Synthetic Peptide to Inhibit Kallikrein for Hereditary Angioedema.
Companies Discussed/Mentioned in this Research:
BioCryst Pharmaceuticals, Inc., Cevec Pharmaceuticals GmbH, CSL Limited, Dyax Corp., Global Blood Therapeutics, Inc., iBio, Inc., Isis Pharmaceuticals, Inc., Pharming Group N.V., Ra Pharmaceuticals, Inc. and Shire Plc
Inquire before buying for this report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=394586 . (This is a premium report price at US$2000 for a single user PDF license)
Scope :
• The report provides a snapshot of the global therapeutic landscape of Hereditary Angioedema (HAE)
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Hereditary Angioedema (HAE) and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Hereditary Angioedema (HAE) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Hereditary Angioedema (HAE) pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products
Reasons to buy :
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Hereditary Angioedema (HAE)
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Hereditary Angioedema (HAE) pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Explore More Research Report on Therapeutics Market.
There has been a great revolution that has been experienced in the field of medical science to make healthy living possible. The contribution of the so much research in the field of therapeutics is noteworthy in this regard. By definition, therapeutics is the field of medical science that deals with the various therapies that can help to cure the disease and pain. In fact, there are different therapies that exist and can provide the treatment in a non-surgical manner. Fighting with the worst of the diseases is only possible with the help of the so much innovation in the field of therapeutics.
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
